Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.6900
+0.0100 (1.47%)
May 13, 2026, 3:59 PM EST
Vaxart Employees
Vaxart had 65 employees as of December 31, 2025. The number of employees decreased by 40 or -38.10% compared to the previous year.
Employees
65
Change (1Y)
-40
Growth (1Y)
-38.10%
Revenue / Employee
$3,932,446
Profits / Employee
$570,723
Market Cap
166.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -40 | -38.10% |
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 142 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| CytoDyn | 13 |
| Nuo Therapeutics | 10 |
| Cell Source | 1 |
Vaxart News
- 5 days ago - Vaxart Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 13 days ago - Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET - GlobeNewsWire
- 20 days ago - Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - GlobeNewsWire
- 27 days ago - Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital - GlobeNewsWire
- 2 months ago - Vaxart Transcript: Fireside chat - Transcripts
- 2 months ago - Vaxart Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire